AbbVie, a global research-driven biopharmaceutical company with a significant presence across six Irish locations, opened a new €23 million European manufacturing services hub in Clonshaugh, North Dublin. The state-of-the-art facility spans two sites within the IDA Business Park in Clonshaugh and serves as an international base for a range of supply chain, manufacturing
Planning permission has been granted for a €45m expansion of biopharmaceutical company, Gilead Sciences, at its Cork manufacturing base in Carrigtwohill. The expansion will ensure that the Cork base continues to play a central master distributor role in Gilead’s global supply chain. Vice President of Manufacturing Operations, David Cadogan, said, “this
Tánaiste Leo Varadkar joined the global CEO of the biopharmaceutical company Ipsen, David Loew, to launch Ipsen’s newly upgraded manufacturing site in Blanchardstown, Dublin. The official site launch follows Ipsen’s recent investment of €52 million to upgrade and expand manufacturing capabilities at the Dublin based site. The investment has supported the extension and